Leucemia/linfoma de células T del adulto. Revisión de la literatura científica

Actas Dermo-Sifiliográficas - Tập 109 - Trang 399-407 - 2018
M.J.M. Rodríguez-Zúñiga1,2, F. Cortez-Franco1, E. Qujiano-Gomero1
1Servicio de Dermatología, Hospital Nacional Daniel Alcides Carrión, Callao, Perú
2Universidad Nacional Mayor de San Marcos, Lima, Perú

Tài liệu tham khảo

Ohshima, 2015, Molecular pathology of adult T-cell leukemia/lymphoma, Oncology., 89, 7, 10.1159/000431058 Satake, 2015, The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan, Leuk Lymphoma., 56, 1806, 10.3109/10428194.2014.964700 Cortez-Franco, 2009, Manifestaciones cutáneas de la infección por el virus linfotrópico T humano (HTLV-I), Dermatol Peru., 19, 49 Ita, 2014, Human T-lymphotropic virus type 1 infection is frequent in rural communities of the southern Andes of Peru, Int J Infect Dis., 19, 46, 10.1016/j.ijid.2013.10.005 Qayyum, 2014, Adult T-cell leukemia/lymphoma, Arch Pathol Lab Med., 138, 282, 10.5858/arpa.2012-0379-RS Chihara, 2012, Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States, Cancer Sci., 103, 1857, 10.1111/j.1349-7006.2012.02373.x Yoshida, 2015, Incidence of adult T-cell leukemia/lymphoma in nonendemic areas, Curr Treat Options Oncol., 16, 7, 10.1007/s11864-014-0321-5 Chihara, 2014, Differences in incidence and trends of haematological malignancies in Japan and the United States, Br J Haematol., 164, 536, 10.1111/bjh.12659 Tokudome, 1989, Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan, Cancer Res., 49, 226 Proietti, 2005, Global epidemiology of HTLV-I infection and associated diseases, Oncogene., 24, 6058, 10.1038/sj.onc.1208968 Tsukasaki, 2014, Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: New directions in clinical research, Clin Cancer Res., 20, 5217, 10.1158/1078-0432.CCR-14-0572 Goncalves, 2010, Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases, Clin Microbiol Rev., 23, 577, 10.1128/CMR.00063-09 Paiva, 2015, Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas, Rev Inst Med Trop Sao Paulo., 57, 1, 10.1590/S0036-46652015000100001 Gotuzzo, 2010, Twenty years of research on HTLV-1 and its medical complications in Peru: General perspectives, Acta Med Per., 27, 196 Fujino, 2000, HTLV-I transmission from mother to child, J Reprod Immunol., 47, 197, 10.1016/S0165-0378(00)00054-1 Yasunaga, 2011, Molecular mechanisms of HTLV-1 infection and pathogenesis, Int J Hematol., 94, 435, 10.1007/s12185-011-0937-1 Ahmadi Ghezeldasht, 2013, Human T lymphotropic virus type I (HTLV-I) oncogenesis: Molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia/lymphoma (ATL), Iran J Basic Med Sci., 16, 179 Marriott, 2005, Impact of HTLV-I tax on cell cycle progression and the cellular DNA damage repair response, Oncogene., 24, 5986, 10.1038/sj.onc.1208976 Tsukasaki, 2013, 2076 Matsuoka, 2009, The HBZ gene, a key player in HTLV-1 pathogenesis, Retrovirology., 6, 71, 10.1186/1742-4690-6-71 Bangham, 2011, Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1, Adv Cancer Res., 111, 163, 10.1016/B978-0-12-385524-4.00004-0 Kobayashi, 2014, CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma, Clin Cancer Res., 20, 2851, 10.1158/1078-0432.CCR-13-3169 Ohshima, 2008, Adult T-cell leukemia/lymphoma Rodriguez-Zuniga, 2017, Adult T-cell leukemia/lymphoma in a Peruvian hospital in human T-lymphotropic virus type 1 (HTLV-1) positive patients, Int J Dermatol., 56, 503, 10.1111/ijd.13567 Jabbour, 2011, Hematopoietic SCT for adult T-cell leukemia/lymphoma: A review, Bone Marrow Transplant., 46, 1039, 10.1038/bmt.2011.27 Bazarbachi, 2011, How I treat adult T-cell leukemia/lymphoma, Blood., 118, 1736, 10.1182/blood-2011-03-345702 Tokura, 2014, Skin manifestations of adult T-cell leukemia/lymphoma: Clinical, cytological and immunological features, J Dermatol., 41, 19, 10.1111/1346-8138.12328 Sawada, 2011, Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma, Blood., 117, 3961, 10.1182/blood-2010-11-316794 Pezeshkpoor, 2008, Specific cutaneous manifestations in adult T-cell leukemia/lymphoma, Int J Dermatol., 47, 359, 10.1111/j.1365-4632.2008.03526.x Michael, 2002, Bullous adult T-cell lymphoma/leukemia and human T-cell lymphotropic virus-1 associated myelopathy in a 60-year-old man, J Am Acad Dermatol., 46, S137, 10.1067/mjd.2002.107232 Hanchard, 1996, Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995, J Acquir Immune Defic Syndr Hum Retrovirol., 13, S20, 10.1097/00042560-199600001-00005 Matutes, 2007, Adult T-cell leukaemia/lymphoma, J Clin Pathol., 60, 1373, 10.1136/jcp.2007.052456 Bittencourt, 2009, Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: Clinical, histological and immunohistochemical features of 52 cases, Acta Oncol., 48, 598, 10.1080/02841860802657235 Yonekura, 2015, Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes, J Dermatol., 42, 1143, 10.1111/1346-8138.13004 Tsukasaki, 2009, Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting, J Clin Oncol., 27, 453, 10.1200/JCO.2008.18.2428 Ohshima, 2007, Pathological features of diseases associated with human T-cell leukemia virus type I, Cancer Sci., 98, 772, 10.1111/j.1349-7006.2007.00456.x Setoyama, 1998, Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma, Am J Pathol., 152, 683 Tsukasaki, 2012, Adult T-cell leukemia-lymphoma, Hematology., 17, S32, 10.1179/102453312X13336169155330 Barnes, 2009, Adult T-cell leukemia/lymphoma: Complexities in diagnosis and novel treatment strategies, Oncology (Williston Park)., 23, 1267 Katsuya, 2012, Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma, J Clin Oncol., 30, 1635, 10.1200/JCO.2011.38.2101 Fukushima, 2014, Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A), Br J Haematol., 166, 739, 10.1111/bjh.12962 Beltran, 2011, Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma, Leuk Res., 35, 334, 10.1016/j.leukres.2010.08.006 Tsukasaki, 2007, VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801, J Clin Oncol., 25, 5458, 10.1200/JCO.2007.11.9958 Bazarbachi, 2010, Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes, J Clin Oncol., 28, 4177, 10.1200/JCO.2010.28.0669 Yared, 2015, Optimizing management of patients with adult T cell leukemia-lymphoma, Cancers (Basel)., 7, 2318, 10.3390/cancers7040893 Kawada, 2015, A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience, Biol Blood Marrow Transplant., 21, 696, 10.1016/j.bbmt.2014.12.020 Fukushima, 2005, Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma, Leukemia., 19, 829, 10.1038/sj.leu.2403682 Fuji, 2016, Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma, Bone Marrow Transplant., 51, 205, 10.1038/bmt.2015.265 Fuji, 2016, Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma, Stem Cell Investig., 3, 70, 10.21037/sci.2016.09.13 Iyama, 2017, A multicenter retrospective study of mogamulizumab efficacy in adult T-cell leukemia/lymphoma, Clin Lymphoma Myeloma Leuk., 17, 23, 10.1016/j.clml.2016.09.009 Yonekura, 2014, Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: Cutaneous adverse reactions may predict the prognosis, J Dermatol., 41, 239, 10.1111/1346-8138.12419 Yamamoto, 2010, Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma, J Clin Oncol., 28, 1591, 10.1200/JCO.2009.25.3575 Ishida, 2015, Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study, Br J Haematol., 169, 672, 10.1111/bjh.13338